In pharmaceutical patent law, the problem of lack of policy
direction and inappropriate legal framework is widespread -
particularly among jurisdictions with little to no pharmaceutical
research or manufacturing. This book aims to inform public policy
and influence debate through a comprehensive review of Hong Kong's
pharmaceutical patent law. By demonstrating the need for a holistic
review of pharmaceutical patent laws and evaluating Hong Kong's
system in light of health policy, economic and social factors,
Bryan Mercurio recommends changes to the legal framework and
constructs a more efficient and effective system for Hong Kong. He
thoroughly evaluates the international framework and best practice
models to offer a global perspective to each issue before providing
local context in the analysis. While the focus of the book is Hong
Kong, the analysis on pharmaceutical patent law and policy extends
to other jurisdictions facing issues on reforming their national
system.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!